Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ShK neurotoxin

Known as: ShK toxin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Shikonin (SHK) has been proven to have a good anti-tumor effect. However, poor water solubility and low bioavailability limit its… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 4
2017
2017
Backgrounds We aimed to evaluate the predictive power of longitudinal and circumferential fibers according to left ventricular… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2014
2014
Objectives To determine the potential association between HPV infection and the squamous cell component of urothelial carcinoma… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
2014
2014
Introduction Despite the crucial role of endothelial progenitor cells (EPCs) in vascular regeneration, the specific interactions… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
2007
2007
Computational methods are employed to simulate the interaction of the sea anemone toxin ShK in complex with the voltage-gated… Expand
Review
2004
Review
2004
Expression of the two lymphocyte potassium channels, the voltage-gated channel Kv1.3 and the calcium activated channel IKCa1… Expand
2003
2003
ShK, a peptide isolated from Stichodactyla helianthus venom, blocks the voltage-gated potassium channels, K(v)1.1 and K(v)1.3… Expand
Highly Cited
2002
Highly Cited
2002
The voltage-gated potassium channel in T lymphocytes, Kv1.3, an important target for immunosuppressants, is blocked by picomolar… Expand
Highly Cited
2001
Highly Cited
2001
Adoptive transfer experimental autoimmune encephalomyelitis (AT-EAE), a disease resembling multiple sclerosis, is induced in rats… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1998
Highly Cited
1998
The voltage-gated potassium channel in T lymphocytes, Kv1.3, is an important molecular target for immunosuppressive agents. A… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4